Category: Genetic Counseling

• Understanding cancer genetic risk assessment motivations in a remote tailored risk communication and navigation intervention randomized controlled trial.
• Le Compte CG, Lu SE, Ani J, McDougall J, Walters ST, Toppmeyer D, Boyce TW, Stroup A, Paddock L, Grumet S, Lin Y, Heidt E, Kinney AY.
• Health Psychol Behav Med. 2022 Dec 9;10(1):1190-1215. doi: 10.1080/21642850.2022.2150623.

• PMID: 36518606
• PubMed abstract
• Source abstract

• Free PMC article
• Free Full Text

Related:

•• Identifier: NCT03326713: Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project (GRACE). (ClinicalTrials.gov . Accessed 2022 Dec 16.)

• Investigating the presentation of uncertainty in an icon array: A randomized trial.
• Recchia G, Lawrence ACE, Freeman ALJ.
• PEC Innov. 2022 Dec;1:None. doi: 10.1016/j.pecinn.2021.100003.

• PMID: 36518604
• PubMed abstract

• Free PMC article
• Free Full Text

• Patient-reported outcomes associated with reflex BRCA1/2 tumor and subsequent germline panel genetic testing for high-grade serous ovarian cancer.
• McCuaig JM, Stockley TL, Ferguson SE, Vicus D, Brennenstuhl S, Ott K, Kim RH, Metcalfe KA.
• J Genet Couns. 2022 Dec 7. doi: 10.1002/jgc4.1661. Epub ahead of print.

• Free Full Text

• Patient uptake of updated genetic testing following uninformative BRCA1 and BRCA2 results.
• Macklin-Mantia SK, Clift KE, Maimone S, Hodge DO, Riegert-Johnson D, Hines SL.
• J Genet Couns. 2022 Dec 7. doi: 10.1002/jgc4.1665. Epub ahead of print.

• Source abstract

• Halo Diagnostics, Ikonopedia Partner to Provide Genetic Testing for Breast Cancer.
• [No author given]
• Precision Oncology News. 2022 Nov 28.

• News
• Free Full Text

• BRCAShare-Assessment of an animated digital message for intrafamilial communication of pathogenic variant positive test results: A feasibility study.
• Aeilts AM, Carpenter KM, Hovick SR, Byrne L, Shoben AB, Senter L.
• J Genet Couns. 2022 Nov 25. doi: 10.1002/jgc4.1656. Epub ahead of print.

• PMID: 36426678
• PubMed abstract
• Source abstract

• Free Full Text

• Testing a deliberative democracy method with citizens of African ancestry to weigh pros and cons of targeted screening for hereditary breast and ovarian cancer risk.
• Guan Y, Pathak S, Ballard D, Veluswamy JK, McCullough LE, McBride CM, Gornick MC.
• Front Public Health. 2022 Nov 8;10:984926. doi: 10.3389/fpubh.2022.984926.

• PMID: 36424974
• PubMed abstract

• Free PMC article
• Free Full Text

• Nest Genomics Building EHR-Integrated Clinical Decision Support for Genetics-Informed Care.
• Cohen JK.
• GenomeWeb. Disease Areas. Cancer. 2022 Oct 25.

• News
• Source abstract

• UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer.
• [No author given]
• GenomeWeb. The Scan. 2022 Nov 23.

• News
• Free Full Text

Related:

•• Original research:

A digital pathway for genetic testing in UK NHS patients with cancer: BRCA-DIRECT randomised study internal pilot.

• PMID: 35868849
• PubMed abstract
• Free Full Text

• Fatalism and metaphor in Confucianism: A qualitative study of barriers to genetic testing among first-degree relatives of hereditary cancer patients from China.
• Jiang C, Liu L, Wang Y, Wu L, Zhang W, Wu X.
• Psychooncology. 2022 Nov 15. doi: 10.1002/pon.6068. Epub ahead of print.

• PMID: 36380559
• PubMed abstract
• Source abstract

• Free Full Text

• Latinx attitudes, barriers, and experiences with genetic counseling and testing: A systematic review.
• Dron HA, Bucio D, Young JL, Tabor HK, Cho MK.
• J Genet Couns. 2022 Oct 27. doi: 10.1002/jgc4.1632. Epub ahead of print.

• PMID: 36301246
• PubMed abstract

• Review
• Free Full Text

• Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline.
• Sessa C, Balmaña J, Bober SL, Cardoso MJ, Colombo N, Curigliano G, Domchek SM, Evans DG, Fischerova D, Harbeck N, Kuhl C, Lemley B, Levy-Lahad E, Lambertini M, Ledermann JA, Loibl S, Phillips KA, Shimon P; ESMO Guidelines Committee.
• Ann Oncol. 2022 Oct 19:S0923-7534(22)04193-X. doi: 10.1016/j.annonc.2022.10.004. Epub ahead of print.

• PMID: 36307055
• PubMed abstract

• Guideline
• Free Full Text

• Development of a web-based, theory-guided narrative intervention for women at elevated risk for breast cancer.
• Katz ML, Senter L, Reiter PL, Emerson B, Ennis AC, Shane-Carson KP, Aeilts A, Cassingham HR, Schnell PM, Agnese DM, Toland AE, Sweet K.
• Patient Educ Couns. 2022 Oct 29:S0738-3991(22)00820-5. doi: 10.1016/j.pec.2022.10.348. Epub ahead of print.

• Source abstract

• Next-generation universal hereditary cancer screening: implementation of an automated hereditary cancer screening program for patients with advanced cancer undergoing tumor sequencing in a large HMO.
• Hoffman TL, Kershberg H, Goff J, Holmquist KJ, Haque R, Alvarado M.
• Fam Cancer. 2022 Oct 20. doi: 10.1007/s10689-022-00317-w. Epub ahead of print.

• PMID: 36261688
• PubMed abstract

• Free Full Text

• Uptake of BRCA1/BRCA2 predictive genetic testing in an Irish population is low: a missed opportunity.
• O'Reilly DE, Dooley L, Watson GA, Clarke R, Nolan A, Nolan C, Berkeley E, Farrell M, McDevitt T, Rogers M, Clabby C, Gallagher DJ.
• Ir J Med Sci. 2022 Oct 19. doi: 10.1007/s11845-022-03176-7. Epub ahead of print.

• PMID: 36260241
• PubMed abstract
• Source abstract